| Title: | Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining |
|---|
| Authors: | ID Jesenko, Tanja (Author)
ID Grašič-Kuhar, Cvetka (Author)
ID Pišljar, Živa (Author)
ID Miceska, Simona (Author)
ID Kloboves-Prevodnik, Veronika (Author)
ID Čemažar, Maja (Author) |
|---|
| Files: |  URL - Source URL, visit https://pmc.ncbi.nlm.nih.gov/articles/PMC12325023/
|
|---|
| Language: | English |
|---|
| Typology: | 1.01 - Original Scientific Article |
|---|
| Organization: |  OI - Institute of Oncology
|
|---|
| Abstract: | Background: Circulating Tumor Cells (CTCs) serve as important biomarkers for disease monitoring and treatment response in patients with metastatic breast cancer. Their detection remains challenging because of their low abundance, phenotypic diversity and non-standardized mode of detection. Cytopathological Giemsa and Immunofluorescence (IF) staining can offer complementary approaches for CTC characterization. Giemsa staining enables assessment of cellular morphology, while IF allows for marker-specific identification, together providing a more comprehensive and accurate evaluation of CTCs. Methods: We developed an IF staining protocol with antibodies against Cytokeratin (CK), vimentin (VIM), and Cluster of Differentiation 45 (CD45) to distinguish epithelial, mesenchymal, hybrid and hematopoietic cells for CTC detection and characterization and compared it with cytopathologic method of detection via Giemsa staining with regard to CTC detection rates and morphological detail. Results: Study was performed on the samples of 29 heavily pretreated patients with metastatic breast cancer (median duration of metastatic disease 19.4 months). Giemsa staining enabled the detection of a higher number of CTCs compared to our IF protocol. Lower detection rate was potentially due to the loss of fragile or loosely adherent cells during methanol fixation and IF staining. Additionally, in IF-stained samples, some CTCs presented faint nuclear signals, potentially impairing their recognition. The IF staining supported the identity of CTCs detected on Giemsa-stained slides by employing a three-color antibody panel-based approach and allowed detailed phenotypic discrimination and structural analysis of CTCs, including the identification of a distinctive CK polarization pattern suggestive of a transitional state during intravasation. Conclusion: Giemsa and IF may thus be complementary rather than mutually exclusive and relying on a single detection approach could underestimate the true CTC burden. An integrative strategy combining both techniques may offer a more comprehensive view of CTC populations in metastatic breast cancer, thereby enhancing diagnostic precision. |
|---|
| Keywords: | biomarkers, breast cancer, circulating tumor cells, cytopathological detection |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Submitted for review: | 20.05.2025 |
|---|
| Article acceptance date: | 09.07.2025 |
|---|
| Publication date: | 23.07.2025 |
|---|
| Publisher: | Frontiers Media SA |
|---|
| Year of publishing: | 2025 |
|---|
| Number of pages: | str. 1632245-1-1632245-13 |
|---|
| Numbering: | Vol. , no. |
|---|
| PID: | 20.500.12556/DiRROS-24408  |
|---|
| UDC: | 616-07 |
|---|
| ISSN on article: | 2234-943X |
|---|
| DOI: | 10.3389/fonc.2025.1632245 |
|---|
| COBISS.SI-ID: | 245945091 |
|---|
| Copyright: | by Authors |
|---|
| Note: | Nasl. z nasl. zaslona;
Opis vira z dne 19. 8. 2025;
|
|---|
| Publication date in DiRROS: | 05.12.2025 |
|---|
| Views: | 96 |
|---|
| Downloads: | 23 |
|---|
| Metadata: |    |
|---|
|
:
|
Copy citation |
|---|
| | | | Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |
